NEW YORK, NY / ACCESSWIRE / August 31, 2016 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against SunPower Corp. (“SunPower” or the “Company”) (NASDAQ: SPWR) and certain of its officers. The class action is on behalf of a class consisting of all persons or entities who purchased SunPower securities between February 17, 2016 through August 9, 2016, inclusive (the “Class Period”).

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange
Act of 1934 (the “Exchange Act”).

SunPower is and American energy company that designs and manufactures sustainable energy products to residential customers, businesses, and institutions.

On August 9, 2016, SunPower released its second quarter 2016 financial results. SunPower did meet some of its projected expectations but also forecast predicted a drop in its coming quarters. SunPower said in part, “we see a number of near-term industry challenges, primarily in our power plant segment, that we expect to impact our business and financial performance in the second half of 2016. The extension of the Investment Tax Credit, as well as the bonus depreciation credit, while beneficial to the long-term health of the industry, has reduced the urgency to complete new solar projects by the end of 2016, with many customers adopting a longer-term timeline for project completion. Additionally, near-term economic returns have deteriorated due to aggressive PPA pricing by new market entrants, including a number of large, global independent power companies.”

Following this news SunPower stock dropped $4.47 per share, or over 30%, to close at $10.31 on August 10, 2016.

The Complaint alleges that throughout the Class Period, Defendants made false and misleading statements and/or failed to disclose: (1) that many of the Company’s customers were adopting a longer-term timeline for project completion; (2) that SunPower’s near-term economic returns were weakening due to forceful PPA pricing by new market competitors; (3) that market disruption in the YieldCo environment was affecting SunPower’s assumptions related to monetizing deferred profits; (4) that the need for SunPower’s products was significantly declining; (5) that SunPower would implement a manufacturing realignment that would result in significant restructuring charges; (6) that the Company’s fiscal year 2016 guidance was inflated; and (7) consequently, SunPower’s statements regarding its business, operations, and prospects, were false and misleading and/or lacked a reasonable basis.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: http://www.bgandg.com/spwr or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484 or via email info@bgandg.com. Those who inquire by e-mail are encouraged to include their mailing address and telephone number. If you suffered a loss in SunPower you have until October 17, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 443999

NEW YORK, NY / ACCESSWIRE / August 31, 2016 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a securities class action has been filed in the United States District Court District of Maryland on behalf of those who purchased shares of Emergent Biosolutions, Inc. (“Emergent” or the “Company”) (NYSE: EBS) during the period between January 11, 2016 and June 21, 2016, inclusive (the “Class Period”).

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the “Exchange Act”).

Emergent is a multinational specialty biopharmaceutical company that develops vaccines and antibody therapeutics for infectious diseases, oncology and autoimmune disorders, and provides medical devices for biodefense purposes. Emergent’s anthrax vaccine, BioThrax (Anthrax Vaccine Adsorbed) (“BioThrax”), is the only Anthrax vaccine licensed by the U.S. Food and Drug Administration (“FDA”). In September 2011, Emergent entered into a five-year procurement contract with the U.S. government for 44.75 million doses of BioThrax and by January 2016, Emergent reported it had sold out of its BioThrax and was expanding its BioThrax manufacturing facilities.

The complaint alleges that during the Class Period, defendants issued materially false and misleading statements regarding the Emergent’s business and financial prospects. Particularly, Emergent had no reason to believe that a renewal of its contract with the U.S. government would involve the same amount of purchases of BioThrax, but Emergent claimed it believed to receive the profitable renewal of its five-year exclusive anthrax vaccine procurement contract. Emergent also emphasized the demand for BioThrax was growing, that the U.S. government would fund Emergent’s development of its BioThrax production facilities, and claimed with no reasonable basis that this development would allow Emergent to manufacture roughly 20 to 25 million additional doses of BioThrax annually, that the U.S. government would purchase over the following five-year period in order to build the U.S. Strategic National Stockpile (“SNS”) of anthrax vaccine to 75 million doses. Following the defendants’ materially false and misleading statements, Emergent stock traded at artificially inflated prices, reaching a Class Period high of $43.95 per share. This inflation enabled certain of the defendants to sell their personal shares of for proceeds of over $14.5 million.

Then on June 22, 2016, pre-market, Emergent revealed that the U.S. government had issued two official solicitation notices specifying that it would only be purchasing 29.4 million doses of the BioThrax vaccine, roughly one-third less than the 44.75 million doses in the first agreement and far under the 75 million doses that Emergent had led their investors to believe. Emergent also released that instead of more first-generation BioThrax anthrax vaccines, the U.S. government wanted newer and faster next-generation anthrax vaccines, and once one would be approved, bids would be placed to other companies and Emergent would lose its exclusivity. Following news, Emergent stock dropped roughly $8.00 per share to close at $31.33 on June 22, 2016.

No Class has yet been certified in the above action. To discuss this action, or for any questions, please visit the firm’s site: http://www.bgandg.com/#!ebs/jbu1a or contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484 or via email info@bgandg.com. Those who inquire by e-mail are encouraged to include their mailing address and telephone number. If you suffered a loss in Emergent, you have until September 19, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 443222

NEW YORK, NY / ACCESSWIRE / August 31, 2016 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a securities class action has been filed on behalf of those who purchased shares of Eaton Corporation plc (“Eaton” or the “Company”) (NYSE: ETN) and certain of its officers, during the period between November 13, 2013 and July 28, 2016, inclusive (the “Class Period”).

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the “Exchange Act”).

The Complaint alleges that Defendants issued false and misleading statements regarding Eaton’s ability to divest its automobile-part manufacturing business. Eaton has primarily focused on vehicle component manufacturing, but as of 2008, Eaton has extended its electrical component businesses. In 2012 Eaton entered a merger with Cooper Industries plc, which reincorporated Eaton in Ireland. Following the Merger, Eaton’s executives guaranteed its shareholders of the feasibility of divesting the automobile-part manufacturing business on a tax-free basis, thus artificially inflating Eaton’s stock price. On July 29, 2014, Eaton’s Chief Executive Officer, Alexander M. Cutler, informed investors that due to the merger with Cooper Industries plc and the associated tax-law restrictions, Eaton would not be able to divest its vehicle business until late. Cutler added the Eaton was “well aware” of these restrictions “all along.” Following this news, Eaton stock dropped $6.24 per share, or 8.13%, to close at $70.51 on July 29, 2014.

No Class has yet been certified in the above action. To discuss this action, or for any questions, please visit the firm’s site: http://www.bgandg.com/#!etn/d4r9k or contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484 or via email info@bgandg.com. Those who inquire by e-mail are encouraged to include their mailing address and telephone number. If you suffered a loss in Eaton, you have until
September 23, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC

Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 443250

NEW YORK, NY / ACCESSWIRE / August 31, 2016 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed in the United States District Court, Middle District of Tennessee, against Corrections Corporation of America (“Corrections Corporation” or the “Company”) (NYSE: CXW) and certain of its officers. The class action is on behalf of a class consisting of all persons or entities who purchased Corrections Corporation securities between February 27, 2012 and August 17, 2016, inclusive (the “Class Period”).

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the “Exchange Act”).

Corrections Corporation, founded in Nashville Tennessee, owns, operates and manages private correctional and detention facilities in the United States. The company also provides inmate residential and prisoner transportation services for governmental agencies.

The Complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding Corrections Corporation’s business, operational and compliance policies. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (1) Corrections Corporation’s facilities lacked adequate safety and security standards and were less efficient at offering correctional services than the Federal Bureau of Prisons’ (“BOP”) facilities; (2) Corrections Corporation’s rehabilitative services for inmates were less effective than those provided by BOP; (3) consequently, the U.S. Department of Justice (“DOJ”) was unlikely to renew and/or extend its contracts with Corrections Corporation; and (4) therefore, Corrections Corporation’s public statements were materially false and misleading at all relevant times.

On August 18, 2016, the Justice Department publicized its plan to terminate its use of private prisons after officials established that private prisons are less safe and less successful in delivering correctional services compared to prisons government run. Corrections Corporation of America is one of three contracted prisons. Following this news Corrections Corporation stock dropped $9.65 per share or over 35% to close at $17.57 on August 18, 2016.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: http://www.bgandg.com/cxw or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484 or via email info@bgandg.com. Those who inquire by e-mail are encouraged to include their mailing address and telephone number. If you suffered a loss in Corrections Corporation you have until October 24, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 444256

NEW YORK, NY / ACCESSWIRE / August 31, 2016 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against Concordia International Corp (“Concordia” or the “Company”) (NASDAQ: CXRX) and certain of its officers. The class action is on behalf of a class consisting of all persons or entities who purchased Concordia securities between November 12, 2015 through August 12, 2016, inclusive (the “Class Period”).

According to the Complaint, throughout the Class Period defendants issued false and misleading statements to investors and/or failed to disclose that: (1) Concordia was suffering a surge in market competition against its drug, Donnatal, and other of its primary products; (2) therefore, Concordia’s financial results be affected and Concordia would have to suspend its dividend; and (3) consequently, defendants’ statements regarding Concordia’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: http://www.bgandg.com/cxrx or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484 or via email info@bgandg.com. Those who inquire by e-mail are encouraged to include their mailing address and telephone number. If you suffered a loss in Concordia you have until October 14, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 443886

NEW YORK, NY / ACCESSWIRE / August 31, 2016 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a securities class action has been filed in the United States District Court, Southern District of New York on behalf of those who purchased shares of Embraer S.A. (“Embraer” or the “Company”) (NYSE: ERJ) between April 16, 2012 and July 28, 2016 inclusive (the “Class Period”).

Embraer designs, develops, manufactures, and sells aircraft and systems in Brazil, North America, Latin America, the Asia-Pacific region, Europe, and internationally.

The Complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (1) Embraer paid bribes to Dominican Republic officials to secure contracts for aircraft sales; (2) Embraer’s President and Chief Executive Officer (“CEO”), Defendant Frederico Pinheiro Fleury Curado (“Curado”) had knowledge of the bribe; (3) the predictable consequences of this misconduct would cost Embraer hundreds of millions of dollars; and (4) consequently, Defendants’ statements about Embraer’s business, operations, and prospects were false and misleading and/or lacked a reasonable basis.

On November 1, 2013, post-market, The Wall Street Journal published an article explaining that Embraer was under investigation by the U.S. and Brazilian governments regarding a bribery scheme with Dominican Republic officials to close a deal for military aircrafts. Following this news, Embraer’s ADRs dropped $0.17 per share, or 0.57%, to close at $29.55 on (the next trading day,) November 4, 2013.

On September 23, 2014, The Wall Street Journal published how the Brazilian authorities filed a criminal complaint with charges of bribery against an Embraer sales consultant and eight former Ebraer executives and directors for Embraer, which had seemingly been done with the approval of Embraer’s top management. The charges were based on evidence provided by U.S. authorities, who had been investigating Embraer possible violations of the U.S. Foreign Corrupt Practices Act (“FCPA”) since 2010. Embraer had bribed Dominican Republic officials to secure a $92 million contract. Following this news, Embraer’s ADRs dropped $0.26 per share, or 0.68%, to close at $38.25 on September 24, 2014.

On March 16, 2016, post-market, several news sources reported that sales consultant Elio Moti Sonnenfeld, who allegedly paid bribes for Embraer, told Brazilian autthorities that he believed Embraer’s top managers, including Defendant Curado, knew of the criminal ‘imbursements’ that were paid for the Dominican Republic sales.

On June 9, 2016, post-market, Embraer announced that Embraer stated that its Chief Executive Officer Frederico Curado would be stepping down after 32 years with the Company, and that Paulo César de Souza e Silva would fill the position. Following this news, Embraer’s ADRs dropped $1.18 per share, or 5.44%, to close at $20.51 on June 10, 2016.

Later, on July 29, 2016, Embraer filed a Form 6-K with the SEC and stated in part: “[N]egotiations with the U.S. Department of Justice (DOJ) and the Securities and Exchange Commission (SEC) for the settlement of the allegations of non-compliance with the U.S. Foreign Corrupt Practices Act (FCPA) have significantly progressed, to the point that Embraer is recognizing a US$ 200 million loss contingency in the quarter ended June 30, 2016.”

The Company also released its quarterly financial report, showing a loss of $99.4 million, or $0.55 per share, after setting aside $200 million in connection with the U.S. FCPA probe. Following this news, Embraer’s ADRs dropped $2.93 per share, or 13.82%, to close at $18.27 on July 29, 2016.

No Class has yet been certified in the above action. If you wish to review a copy of the Complaint or join the action, please visit the firm’s site: http://www.bgandg.com/erj. To discuss this action, or for any questions, please contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484 or via email info@bgandg.com. Those who inquire by e-mail are encouraged to include their mailing address and telephone number. If you suffered a loss in Embraer you have until
October 7, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 443441

NEW YORK, NY / ACCESSWIRE / August 31, 2016 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been against Goldcorp, Inc. (“Goldcorp” or the “Company”) (NYSE: GG) and certain of its officers. The class action is on behalf of a class consisting of all persons or entities who purchased Goldcorp securities between March 31, 2014 and August 24, 2016, inclusive (the “Class Period”).

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the “Exchange Act”).

The Complaint alleges that throughout the Class Period, defendants made materially false and/or misleading statements and/or failed to disclose that: (1) levels of the mineral selenium rose in one groundwater monitoring well near the Peñasquito Mine as early as October 2013; (2) in October 2014, Goldcorp reported a rise in selenium levels in groundwater to the Mexican government after the contamination near the Peñasquito Mine waste facility intensified; (3) in August 2016, Goldcorp told Mexican regulators that contaminated water had also been found in other areas near the Peñasquito Mine; and (4) consequently, the company’s public statements were materially false and misleading at all relevant times.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: http://www.bgandg.com/gg or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484 or via email info@bgandg.com. Those who inquire by e-mail are encouraged to include their mailing address and telephone number. If you suffered a loss in Goldcorp you have until October 24, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 444339

NEW YORK, NY / ACCESSWIRE / August 31, 2016 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Flower Foods, Inc. (“Flower Foods” or the “Company”) (NYSE: FLO) and certain of its officers. The class action was filed on behalf of a class consisting of all persons or entities who purchased Flower Foods securities between February 7, 2013 through August 10, 2016, both dates inclusive (the “Class Period”).

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the “Exchange Act”).

The Complaint alleges that throughout the Class Period defendants issued false and misleading statements to investors and/or failed to disclose that: (1) Flowers Foods was inappropriately classifying employees as independent contractors; (2) this improper documentation exposed Flowers Foods to legal liability and/or negative regulatory action; (3) correct and proper classification would have a negative impact on Flowers Foods’ operations; and (4) consequentially, Flowers Foods’ public statements were materially false and misleading at all relevant times.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: http://www.bgandg.com/flo or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484 or via email info@bgandg.com. Those who inquire by e-mail are encouraged to include their mailing address and telephone number. If you suffered a loss in Flower Foods you have until October
11, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 443790

NEW YORK, NY / ACCESSWIRE / August 31, 2016 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been against Global Digital Solutions (“Global Digital” or the “Company”) (OTCMKT: GDSI) and certain of its officers. The class action is on behalf of a class consisting of all persons or entities who purchased Global Digital securities between October 8, 2013 and August 12, 2016, inclusive (the “Class Period”).

This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the “Exchange Act”).

The Complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that: (1) Airtronic USA, Inc.’s original equipment manufacturer supplier agreement that Global Digital disclosed in its October 2013 press releases did not exist; (2) Global Digital failed to remove these misleading statements from its website despite repeated requests to do so from Airtronic’s CEO; (3) Global Digital lacked a reasonable basis for its revenue projection for 2014; (4) Global Digital had no credible financing in place to acquire any company; (5) Global Digital received various communications indicating Remington Outdoor Company, Inc. had no interest in Global Digital’s unsolicited acquisition offer; (6) Remington had already rejected Global Digital’s offer on several occasions; and (7) consequently, defendants’ statements about Global Digital’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint you can visit the firm’s site: http://www.bgandg.com/gdsi or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484 or via email info@bgandg.com. Those who inquire by e-mail are encouraged to include their mailing address and telephone number. If you suffered a loss in Global Digital you have until October 24, 2016 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

ReleaseID: 444337